EUCTR2005-001622-91-GB进行中（未招募）不适用
A randomised assessor blinded study to examine the role of skin testing in the prediction of peri-operative anaphylaxis and its correlation with mast cell tryptase and total IgE. - Peri-operative screening for sensitization to NMDAs
Royal Group Hospitals0 个研究点目标入组 160 人开始时间: 2005年5月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •i) ASA class I-II
- •ii) Scheduled for elective surgery that involves anaesthesia and the use of neuromuscular blocking drugs and expected to last at least 1 hour.
- •iii) Scheduled for elective surgery with no anticipated large blood loss or fluid shifts
- •iv) Planned post-operative in patient stay to last at least four days.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •i) No previous history of anaphylaxis.
- •ii) No previous reaction to any of the medications used.
- •iii) Pregnancy.
- •iv) Acute exacerbation of any pre-existing disease.
- •v) Not on any steroid or anti-histamine medication at time of testing.
研究者
相似试验
尚未招募
3 期
Management of chronic stable angina with an integrated approach of allopathic and ayurvedic medicationsCTRI/2023/06/054147Shathyu Ayurveda Pvt Ltd
已完成
不适用
Reducing radiation exposure during InterStim lead placementOveractive bladder, fecal incontinenceNervous System DiseasesISRCTN37385347Metro Health Hospital40
已完成
不适用
Surgical transversus abdominis plane (TAP) blocks for post-operative pain relief following lower segment caesarean section (LSCS) under spinal anaesthesia.Post-operative pain following lower segment caesarean sectionACTRN12617000589381James Griffiths100
尚未招募
3 期
A clinical trial to see the effectiveness of homoeopathic medicines in cases of primary idiopathic osteoarthritis of knee above the age group of 40 yearsCTRI/2022/01/039202Dr Samartha Singh
进行中（未招募）
1 期
Clinical trial MV-CHIK-205 is designed to investigate the safety, tolerability, and long-term immunogenicity of a novel vaccine designed to protect against chikungunya virus, a mosquito-borne pathogen causing chikungunya fever throughout tropical areas worldwide.The study is being conducted in healthy volunteers for the prophylaxis of chikungunya virus (CHIKV) infection.EUCTR2018-000211-25-GBThemis Bioscience GmbH60